Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SNG001 inhaled interferon beta-1a trial for COVID-19
ISRCTN14241621Phase 2Completed
- Sponsor
- Synairgen
- Start
- Mar 2020
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
01
Overview
Phase 2, randomised trial of interferon beta-1a in coronavirus disease 2019 (COVID-19) (6 arms), sponsored by Synairgen. Primary endpoint: Change in clinical condition on Ordinal Scale for Clinical Improvement. Started Mar 2020; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ISRCTN14241621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN14241621.